X0508 4 2024-02-27 false 0001645113 NovoCure Ltd NVCR 0001822879 Leonard Frank X C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false EVP, Pres., Novocure Oncology false Ordinary Shares 2024-02-27 4 A false 102249.00 16.30 A 164695.00 D Ordinary Shares 2024-02-28 4 S false 2078.00 16.1428 D 162617.00 D Stock Options (Right to buy) 16.30 2024-02-27 4 A false 156348.00 16.30 A 2025-02-27 2034-02-26 Ordinary Shares 156348.00 156348.00 D Represents restricted share units that are scheduled to vest in equal installments on February 27, 2025, 2026 and 2027, subject to the reporting person's continued employment through such dates. Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Options to buy 156,348 ordinary shares will vest in equal installments on each of February 27, 2025, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates. Steven Robbins, as attorney in fact for Leonard, Frank X. 2024-02-29